Hormonal Disorders

Pipeline Moves: Novartis completes ulcerative colitis trial, advancement prospects rise

This week on Pipeline Moves, we start with the completion of Novartis’s Phase II trial in ulcerative colitis. We also…

DCT Adoption Tracker reveals top therapy areas using a decentralisation approach

Telemedicine remains the leading decentralisation approach in clinical trials in Q2 of this year. The continued rise of telemedicine as…

Pipeline Moves: Phase I/II cystic fibrosis trial of Horizon asset cancelled, shot at further study drops

In this edition of Pipeline Moves, the Clinical Trials Arena team kicks off with an analysis of the termination of…

OPKO Health and Pfizer report positive Phase III data for somatrogon

OPKO Health and Pfizer have reported positive results from the Phase III clinical trial of somatrogon compared to Genotropin (somatropin)…